References
- Wajcman H, Préhu C, Bardakdjian-Michau J, et al. Abnormal hemoglobins: laboratory methods. Hemoglobin. 2001;25(2):169–181.
- Thom CS, Dickson CF, Gell DA, et al. Hemoglobin variants: biochemical properties and clinical correlates. Cold Spring Harb Perspect Med. 2013;3(3):a011858.
- Shaji RV, Edison ES, Krishnamoorthy R, et al. Hb Lepore in the Indian population. Hemoglobin. 2003;27(1):7–14.
- Nieto JM, González FA, Alonso JM, et al. Hb Palencia: a novel δβδ-type two-way fusion variant with β-globin-like expression levels. J Clin Pathol. 2019;72(1):46–51.
- Shin S-Y, Bang S-M, Kim H-J. A novel hemoglobin variant associated with congenital erythrocytosis: Hb Seoul [β86(F2)Ala→Thr] (HBB:c.259G>A). Ann Clin Lab Sci. 2016;46(3):312–314.
- Pagano L, Salzano AM, Carbone V, et al. Hb Cardarelli [β86(F2)Ala→Pro]: a new unstable and hyperaffine variant in association with β+-thalassemia. Hemoglobin. 2004;28(2):103–115.
- Hoyer JD, Wendt PC, Hogan WJ, et al. Hb Nebraska [β86(F2)Ala→Ile (HBB:c.259G>A;260C>T)]: a unique high oxygen affinity hemoglobin variant with a double nucleotide substitution within the same codon. Hemoglobin. 2011;35(1):22–27.
- Tagawa Y, Fujinami S, Kadota Y, et al. Hb Olomouc [α 2 β 2(86)(F2)Ala→Asp] found in a Japanese family. Hemoglobin. 1992;16(1–2):73–76.
- Çelebiler A, Aksoy D, Ocakcı S, et al. A new hemoglobin variant: Hb Izmir [β86(F2)Ala→Val, GCC>GTC; HBB:c.260C>T]. Hemoglobin. 2012;36(5):474–479.
- Qualtieri A, Andreoli V, Crescibene L, et al. Hb Valletta [β 87(F3)Thr→Pro] due to an A→C substitution at codon 87 in a Calabrian family with α-thalassemia. Hemoglobin. 1997;21(1):97–103.
- Witkowska HE, Lubin BH, Beuzard Y, et al. Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-Chori. N Engl J Med. 1991;325(16):1150–1154.
- Castro O, Winter WP, Bullock WH, et al. Hemoglobin D Ibadan trait in combination with sigma β thalassemia. Hemoglobin. 1979;3(1):77–82.
- Zhang H, Li C, Li J, et al. Next-generation sequencing improves molecular epidemiological characterization of thalassemia in Chenzhou Region, P.R. China. J Clin Lab Anal. 2019;33(4):e22845.
- Achour A, Koopmann TT, Baas F, et al. The evolving role of next-generation sequencing in screening and diagnosis of hemoglobinopathies. Front Physiol. 2021;12:686689.
- He J, Song W, Yang J, et al. Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China. Genet Med. 2017;19(9):1022–1031.